4
Changes in Ownership
TransMedics Group, Inc. Filed Acc 0000899243-21-010701
Chief Commercial Officer sold 40,000 shares at an average $31.45 ($1,258,099)
- Chief Commercial Officer acquired 40,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Khayal Tamer I · Chief Commercial Officer
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-03-05 | Exercise or conversion : show line 1 in the form | +14,548 | $0.39 | $5,674 | 60,624 | D |
| 2021-03-05 | Exercise or conversion : show line 2 in the form | +5,452 | $0.28 | $1,527 | 66,076 | D |
| 2021-03-05 | Sale : show line 3 in the form | −5,783 | $30.45 | $176,092 | 60,293 | D |
| 2021-03-05 | Sale : show line 4 in the form | −14,217 | $31.09 | $442,007 | 46,076 | D |
| 2021-03-08 | Exercise or conversion : show line 5 in the form | +20,000 | $0.28 | $5,600 | 66,076 | D |
| 2021-03-08 | Sale : show line 6 in the form | −20,000 | $32.00 | $640,000 | 46,076 | D |
| Open-market sales · 40,000 sh · avg $31.45 · $1,258,099 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2021-03-05 | Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) | −14,548 | $0.39 | 2021-09-27 | 14,548 | 0 | D |
| 2021-03-05 | Exercise or conversion : show line 8 in the form Stock Option (Right to Buy) | −5,452 | $0.28 | 2023-05-29 | 5,452 | 52,177 | D |
| 2021-03-08 | Exercise or conversion : show line 9 in the form Stock Option (Right to Buy) | −20,000 | $0.28 | 2023-05-29 | 20,000 | 32,177 | D |
Loading xslF345X03/doc4.xml…